Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to give written, signed, and dated consent before any study procedures begin
- People aged between 45 and 75 years old
- People with a body mass index (a measure of body weight relative to height) between 25 and 35
- People who have been diagnosed with type 2 diabetes for at least 1 year but no longer than 5 years
- People whose HbA1c (a blood test that shows average blood sugar levels over roughly 3 months) is between 6.5% and 8.5%
- People whose fasting blood sugar level is below 130 mg/dL
- Women who have gone through menopause, meaning their periods stopped more than 1 year ago
- People who have been on a stable dose of metformin and/or sulfonylurea diabetes medicines for at least the past 3 months, and have not taken other diabetes medicines
Who may not be able to join:
- People with type 1 diabetes
- People with heart failure, or serious kidney or liver problems
- People who cannot have an MRI or MRS scan (a type of medical imaging) for any reason
- People with an active diabetic foot (an open wound or infection on the foot related to diabetes)
- People with nerve damage (polyneuropathy) or eye damage (retinopathy) related to diabetes
- People showing signs of active liver or kidney problems
- People with a body mass index above 35
- People currently using insulin injections
- People who have used any diabetes medicine other than metformin or sulfonylurea in the 3 months before the study screening
- People who use SGLT2 inhibitors (a type of diabetes medication)
- People whose body weight has changed by more than 5 kg in the last 3 months
- People currently following a weight loss diet or using weight loss medicines or supplements
- People with high blood pressure that is not well controlled
- People who are already doing a regular exercise program, or who have any other medical condition that could make it unsafe to take part in the study activities
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rodrigo Mancilla, PhD, Finis Terrae University
Phone: +56953676588
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Insulin-stimulated non-oxidative plasma glucose disposal (NOGD)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.